Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8949941 | Pathology - Research and Practice | 2018 | 6 Pages |
Abstract
The clinical presentation of SLCTs can be both varied and complex. Pathological examination is imperative for both diagnostic and prognostic grading. Immunohistochemical stain of α-inhibin, FOXL2, and calretinin and genetic testing for DICER1 mutations will be more potent for differential diagnosis.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Xiaobo Zhang, Danhua Shen, Ying Wang,